Dr. Hunter is Elected to the Board of Director for the North American Neuromodulation Society (NANS)

Dr. Hunter was elected to the Board of Directors of the prestigious North American Neuromodulation Society (NANS) Dr. Hunter has joined the ranks of some of THE most prestigious pain doctors in the country with this latest achievement. Dr. Hunter was appointed to the board after winning an election by his peers this last January of 2018. He will begin his 2-year term as a Director-at-Large for NANS immediately following the annual meeting in Las Vegas. Dr. Hunter has been working very closely with and for NANS for the last several years, particularly on the Advocacy and Policy Board were he has been serving as a delegate to the American Medical Association (AMA).

Drs. Hunter & Lee Implant the First DRG Stimulator in the United States

CRPS Treatment New York City DRG Stimulator

First DRG Stimulator Implant in the Country Performed in New York City! On April 8th, 2016, the Ainsworth Institute made medical history: Drs. Hunter and Lee implanted the very first DRG Stimulator in the entire country - right here in New York. The procedure took record time and the patient was discharged home just a few hours after the procedure was completed. The patient had been living with Complex Regional Pain Syndrome (CRPS) for years after a work-related accident. Her previous pain doctor implanted her a traditional spinal cord stimulator several years prior which helped control her pain to a modest degree; however she was living with constant pain and had trouble sitting down or even walking. In 2015, she was referred to the Ainsworth Institute to see if further treatment could be recommended for her. Luckily, our doctors are part of…

Dorsal Root Ganglion (DRG) Spinal Cord Stimulation Comes to NYC

Corey Hunter, M.D.
Blog, Featured, News

The Ainsworth Institute is one of just 26 sites in the nation selected to start performing the cutting-edge technology! DRG Stimulation is a variation of traditional spinal cord stimulation. The difference is that the leads are a fraction of the size and are placed directly over the individual nerves of the spine, more specifically, the small structures that house the neurons themselves - the Dorsal Root Ganglion (DRG). The ACCURATE study (an FDA-approved clinical trial performed by leading pain physicians in the United States) was completed in 2015 and the results were presented at the North American Neuromodulation Society meeting in the same year. The results were impressive to say the least! It showed DRG was superior in almost way to traditional stimulation with better success rates and better overall pain relief. Dr. Hunter has been selected as one of the…

Dr. Hunter performs first Invisible Trial in New York

Dr. Hunter just performed the first Invisible Spinal Cord Stimulator (SCS) Trial in the state of New York! The Invisible Trial system was developed by St Jude Medical and presents a major leap forward for the technology. This device interfaces with Apple devices allowing patients the ability to control their pain relief with the touch of a finger. What's even more impressive is the trial is totally wireless! Read more about the Invisible Trial System...

Drs. Hunter and Lee present at the joint New York and New Jersey Society of Interventional Pain Physicians (NYSIPP/NJSIPP)

Drs. Hunter and Lee presented at the joint meeting of the New York and New Jersey Society of Interventional Pain Physicians (NYSIPP & NJSIPP). Dr. Hunter lectured on the use of Spinal Cord Stimulation (SCS) for Pelvic Pain. Dr. Lee was chosen to train physicians on the use of Radiofrequency Ablation (RFA) of joint pain.

Why Choose Spinal Cord Stimulation (SCS)?

Spinal Cord Stimulation NYC New York City Manhattan

Spinal Cord Stimulation (SCS) is a particularly appealing option for those with chronic who are hoping to avoid surgery. The field of Neuromodulation (aka neuroaugmentation, aka neurostimulation) was born from the need to find an alternative to surgery. SCS adheres to the fundamental principles of Minimally Invasive Surgery (MIS) by avoiding the excessive tissue injury and scarring inherent to open surgery. The important thing to remember is a SCS trial is not surgery, in fact there is no cutting of any kind. Patients get to test out the neurostimulation in a fully reversible fashion to see if it works and is effective in treating their specific pain complaints. Everyone’s pain is different and no two person’s complaints are the same. This may explain why spinal surgery is successful in some (61%)[1] yet in others their pain is made worse – the…

Dr. Hunter Has Officially Become a Consultant and Speaker for St. Jude Medical

St. Jude Medical is a medical device company on the forefront of innovation in a number of specialties, particularly pain management. Dr. Hunter accepted a position an official consultant and speaker for the company. He has now joined the ranks of some of the most well-respected and world-renowned pain management specialists from around the world to be a part of their team.

Dr. Hunter Gives Grand Rounds at the Weill Cornell Medical Center on Neuromodulation

For the second time this year, Dr. Hunter was bestowed the privilege of giving grand rounds at the Pain Department at the Weill Cornell Medical Center. In attendance were doctors from New York-Presbyterian Hospital, Memorial Sloan Kettering Cancer Center, and Hospital for Special Surgery. Dr. Hunter's lecture was titled "Advances in Neuromodulation" where he discussed the current and future trends in the use of Spinal Cord Stimulation for the treatment of pain.

Dr. Hunter Joins the Editorial Staff for the Medical Journal "Neuromodulation"

The International Neuromodulation Society is the world is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation - the alteration of nerve activity through the delivery of electrical stimulation or chemical agents to targeted sites of the body. Founded in 1989 and based in San Francisco, CA, the INS educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, explanatory content, and chapter websites. Dr. Hunter has just joined the editorial staff where he will be responsible for reviewing manuscripts submitted for publication from around the world.